Follow us on
Search News Archives
Conferences | Events
Monthly Newsletter
Lab Bulletin Media Partners

MediSieve Impresses Biotech Industry

publication date: Nov 8, 2018
 | 
author/source: MediSieve

George Frodsham


MediSieve wins 1st runner up at prestigious Boston Biotech Week start up competition

Medical device company, MediSieve, received accolades for their ground breaking work during the Biotech Week held in Boston in September 2018. MediSieve won first runner up for Best Business Plan at the Xcelerate Startup Pitch Competition hosted by Xcelerate Insight and EBD Group. The pitch competition is designed to give early stage companies exposure to possible investors and partners. It is judged by top venture capitalists and industry experts. 

MediSieve is a medical device company whose magnetic blood filtration system has the ability to specifically and selectively remove disease-causing agents from the blood. The technology has the potential to transform the treatment of blood borne diseases such as sepsis, leukaemia and malaria. 

George Frodsham, CEO at MediSieve explained that "Our pioneering technology involves targeting specific components that cause the diseases and removing them from the patient’s bloodstream. This provides clinicians with a tool to target and remove infected cells, pathogens, toxins, cytokines and others. We are delighted to have received the first runner up award at the Xcelerate Startup Pitch Competition as we were up against many other excellent entrepreneurs in the field of life science." George explains how he started the company and the amazing potential of their technology in this interview.

Along with 16 other entrepreneurs, MediSieve presented at the Xcelerate Startup Pitch competition at BioPharm America earlier this month. All the entrepreneurs presented major undertakings which will have a major impact in life science. Each start up presented their business, with visuals, to an audience which included a panel of investor judges.

Only five of the startups in attendance received an award, with RubrYcs Therapeutic winning the competition.

On the judging panel were: Cheryl Cui of Nest.Bio Ventures, Janelle Anderson of Versant Ventures, Christine Brennan of MRL Ventures Fund, Matthew Hammond of RA Capital Management, Stefan Vitorovic of Vida Ventures, and Paulina Hill of Polaris Partners.

The first runners up were: for best pitch, VisikolInc and for best business plan, MediSieve Limited. The second runners up were: for best pitch, Envisagenics and for best business plan, Cairn Biosciences.




 

Popular this month


Win an INTEGRA VOYAGER adjustable tip spacing pipette


Leeds Teaching Hospitals NHS Trust Pathology Lab to digitally scan 100% of slides


Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins


FreeLIMS.org launches a free, Laboratory Information Management System


Mira P for the pharmaceutical industry: Instant onsite verification of raw materials


Take your microwell plate pipetting to the next level!


World’s first high throughput microplate reader for circular dichroism


Eppendorf Presents First Internally Developed CO2 Incubator


Three benefits of hiring freelance Scientists


 

Can't find what you are looking for?


Search by company or by product


Company Name:

Product:





Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd